CSIMarket Company Name, Ticker, Customers, else..
 
Bluejay Diagnostics Inc   (BJDX)
Other Ticker:  
 
 
Price: $3.2200 $-0.01 -0.310%
Day's High: $3.22 Week Perf: 1.9 %
Day's Low: $ 3.16 30 Day Perf: -7.2 %
Volume (M): 1 52 Wk High: $ 11.14
Volume (M$): $ 3 52 Wk Avg: $2.06
Open: $3.17 52 Wk Low: $0.19



 Market Capitalization (Millions $) 4
 Shares Outstanding (Millions) 1
 Employees -
 Revenues (TTM) (Millions $) -
 Net Income (TTM) (Millions $) -10
 Cash Flow (TTM) (Millions $) -14
 Capital Exp. (TTM) (Millions $) 2

Bluejay Diagnostics Inc


   Company Address: 360 Massachusetts Avenue Acton 1720 MA
   Company Phone Number: 327-7078   Stock Exchange / Ticker: NASDAQ BJDX
   BJDX is expected to report next financial results on March 19, 2024.


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Aurora Technology Acquisition Corp

ATAK, contraction in the operating behavior throughout the July to September 30 2023 period

While the earnings season of the July to September 30 2023 continues, many businesses have reported the earnings. Among them, have been many corporations in the Medical Equipment and Supplies industry. And now, ATAK issued operating deficit of $-0.4793 million, for the third quarter of 2023 earnings season.

Vivos Therapeutics Inc

Vivos Therapeutics Inc. Defies Financial Odds in the Demanding Times of September 2023

For the fiscal time-frame closing September 30 2023 Vivos Therapeutics Inc decreased a loss per share of $-1.75 per share compare to $-6.50 a year before and Income per Share improved from $-4.50 per share from the preceding reporting season. The revenue crumbled by -31.748 % to $2.90 million from $4.25 million in the corresponding reporting season a year before and sequentially Revenue decreased by -6.456 % from $3.10 million.

Vystar Corporation

Devastating Blow: Medical Equipment and Supplies Company Suffers Major Setback in Q3 2023 Financial Report

For the financial interval ending September 30 2023 Vystar Corporation decreased a loss per share of $-0.03 per share compare to $-0.23 a year prior and Income per Share improved from $-0.04 per share from the previous reporting season. The revenue went down sharply by -98.311 % to $0.06 million from $3.57 million in the comparable reporting season a year prior and sequentially revenue surged by 67.054 % from $0.04 million. The remainder ofMedical Equipment and Supplies sector, posted a revenue improvement in the third quarter of 2023.

Petvivo Holdings Inc

Petvivo Holdings Inc Experiences Widening Losses in Q2 2024 Amid Decrease in Orders


As an investor closely following Petvivo Holdings Inc, the recent financial results have presented a mixed bag of challenges and opportunities. In the second quarter of 2024, the company experienced lower turnover, resulting in a significant revenue decrease and a larger shortfall per share compared to the previous year. However, there were notable signs of potential growth and increasing demand within the Medical Equipment and Supplies industry.
One of the key financial indicators is the revenue, which decreased by -7.127% to $0.21 million year on year. This decline is concerning for Petvivo Holdings Inc, as it points to potential shortcomings in the company's ability to generate sales. Comparatively, the Medical Equipment and Supplies industry as a whole recorded a top-line rise in the same period, suggesting that Petvivo may be facing certain internal challenges.
Ir Med Inc

Ir Med Inc announced operating profit of $1.197 million, in the third quarter of 2023 financial report


As an observer of the Medical Equipment and Supplies sector, I have thoroughly analyzed the third quarter financial results of Ir Med Inc. The company's performance took center stage in this report, overshadowing the same period in the previous year. Despite operating predominantly in the development phase, Ir Med Inc showcased a bullish quarter, signaling potential growth prospects.
Notably, Ir Med Inc reported an operating profit of $1.197 million for the July to September 30, 2023 quarter, without any reported revenue. This indicates that the company is focusing on developing its services rather than generating immediate revenue. Such a strategic course of action is crucial for a business aiming to establish a strong foundation before entering the market.





 




Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com